MX2016003014A - Extracto de filipendula vulgaris y usos del mismo. - Google Patents

Extracto de filipendula vulgaris y usos del mismo.

Info

Publication number
MX2016003014A
MX2016003014A MX2016003014A MX2016003014A MX2016003014A MX 2016003014 A MX2016003014 A MX 2016003014A MX 2016003014 A MX2016003014 A MX 2016003014A MX 2016003014 A MX2016003014 A MX 2016003014A MX 2016003014 A MX2016003014 A MX 2016003014A
Authority
MX
Mexico
Prior art keywords
vulgaris extract
filipendula vulgaris
extract
filipendula
kits
Prior art date
Application number
MX2016003014A
Other languages
English (en)
Inventor
Mercati Valentino
Maidecchi Anna
Original Assignee
Aboca S P A Società Agricola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aboca S P A Società Agricola filed Critical Aboca S P A Società Agricola
Publication of MX2016003014A publication Critical patent/MX2016003014A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un extracto de Filipendula vulgaris y también a composiciones y kits que comprenden dicho extracto para la prevención y/o el tratamiento de una condición patológica caracterizada por una activación constitutiva del factor de transcripción STAT3.
MX2016003014A 2013-09-11 2014-09-11 Extracto de filipendula vulgaris y usos del mismo. MX2016003014A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000502A ITRM20130502A1 (it) 2013-09-11 2013-09-11 Estratto di filipendula vulgaris e suoi usi
PCT/IB2014/064422 WO2015036949A1 (en) 2013-09-11 2014-09-11 Filipendula vulgaris extract and uses thereof

Publications (1)

Publication Number Publication Date
MX2016003014A true MX2016003014A (es) 2017-01-05

Family

ID=49554418

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003014A MX2016003014A (es) 2013-09-11 2014-09-11 Extracto de filipendula vulgaris y usos del mismo.

Country Status (12)

Country Link
US (1) US20160213729A1 (es)
EP (1) EP3043809B1 (es)
JP (1) JP2016530326A (es)
CN (1) CN105517558A (es)
AU (1) AU2014319951B2 (es)
CA (1) CA2923894A1 (es)
EA (1) EA201690334A1 (es)
ES (1) ES2666422T3 (es)
IT (1) ITRM20130502A1 (es)
MX (1) MX2016003014A (es)
PT (1) PT3043809T (es)
WO (1) WO2015036949A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2613189C1 (ru) * 2016-04-11 2017-03-15 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Д. Гольдберга" Средство, повышающее антиметастатическую активность циклофосфана
KR102221265B1 (ko) 2019-10-10 2021-03-04 한국과학기술연구원 터리풀 추출물을 포함하는 혈중 콜레스테롤 감소 및 죽상동맥경화증 개선용 식품 조성물 및 치료용 약학 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010025574A (ko) * 2001-01-08 2001-04-06 박건영 암예방 식이 조성물
KR20010035299A (ko) * 2001-02-01 2001-05-07 박건영 암예방 생식 조성물
WO2006039807A1 (en) * 2004-10-15 2006-04-20 Biopharmacopae Design International Inc. Methods and therapeutic compositions comprising plant extracts for the treatment of cancer

Also Published As

Publication number Publication date
ITRM20130502A1 (it) 2015-03-12
EA201690334A1 (ru) 2016-07-29
CN105517558A (zh) 2016-04-20
US20160213729A1 (en) 2016-07-28
AU2014319951A1 (en) 2016-03-10
ES2666422T3 (es) 2018-05-04
PT3043809T (pt) 2018-04-09
JP2016530326A (ja) 2016-09-29
EP3043809B1 (en) 2018-01-31
EP3043809A1 (en) 2016-07-20
WO2015036949A1 (en) 2015-03-19
AU2014319951B2 (en) 2017-04-20
CA2923894A1 (en) 2015-03-19

Similar Documents

Publication Publication Date Title
MX2015012401A (es) Composiciones y metodos de alterar niveles de colesterol.
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
MX2017002538A (es) Absorbedor para unión de metales y la producción del mismo.
AU2016263598A8 (en) Methods and kits for treating depression
NZ726859A (en) Synthesis of polycyclic-carbamoylpyridone compounds
PH12015502141A1 (en) Substituted xanthines and methods of use thereof
MX359907B (es) Aleación de fundición de aluminio.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX360814B (es) Metodo mejorado para producir extractos de ginkgo.
MX2015006337A (es) Metodos y composiciones para tratar enfermedades neurodegenerativas.
NZ729087A (en) Azetidinyloxyphenylpyrrolidine compounds
AU2014224814A8 (en) Novel halogen-substituted compounds
PH12016500903A1 (en) Novel methods for treating neurodegenerative diseases
PH12016501201A1 (en) Synthesis of ent-progesterone and intermediates thereof
MX2023009432A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio.
MX2015016603A (es) Composiciones de corticosteroides.
MX2017006807A (es) Extractos titulados de cynara scolymus y usos de los mismos.
MX2016003014A (es) Extracto de filipendula vulgaris y usos del mismo.
MX2013002111A (es) Metodos y composiciones para el tratamiento de metastasis del cancer.
PH12016502592A1 (en) 3'-substituted-abscisic acid derivatives
MX371011B (es) Intermediarios y métodos para sintetizar derivados de calicheamicina.
MX2015016270A (es) Extracto de cynara spp. y usos del mismo.
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
MY171860A (en) Method for purifying a crude pnpnh compound